A detailed history of Nisa Investment Advisors, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 332 shares of OCGN stock, worth $258. This represents 0.0% of its overall portfolio holdings.

Number of Shares
332
Previous 960 65.42%
Holding current value
$258
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

SELL
$0.72 - $1.08 $452 - $678
-628 Reduced 65.42%
332 $0
Q3 2024

Oct 24, 2024

BUY
$0.98 - $1.95 $940 - $1,872
960 New
960 $0
Q2 2022

Aug 03, 2022

BUY
$1.83 - $3.45 $7,850 - $14,800
4,290 Added 202.36%
6,410 $15,000
Q1 2022

Apr 29, 2022

SELL
$2.34 - $4.72 $25,459 - $51,353
-10,880 Reduced 83.69%
2,120 $7,000
Q4 2021

Feb 03, 2022

BUY
$4.38 - $15.67 $56,940 - $203,710
13,000 New
13,000 $46,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $169M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.